Works matching AU Espie, Marc


Results: 49
    1
    2

    Exquisite Sensitivity of TP53 Mutant and Basal Breast Cancers to a Dose-Dense Epirubicin--Cyclophosphamide Regimen.

    Published in:
    PLoS Medicine, 2007, v. 4, n. 3, p. 0585, doi. 10.1371/journal.pmed.0040090
    By:
    • Bertheau, Philippe;
    • Turpin, Elisabeth;
    • Rickman, David S.;
    • Espie, Marc;
    • Reyniés, Aurélien;
    • Feugeas, Jean-Paul;
    • Plassa, Louis-François;
    • Soliman, Hany;
    • Varna, Mariana;
    • De Roquancourt, Anne;
    • Lehmann-Che, Jacqueline;
    • Beuzard, Yves;
    • Marty, Michel;
    • Misset, Jean-Louis;
    • Janin, Anne;
    • De Thé, Hugues
    Publication type:
    Article
    3

    Intraoperative Radiotherapy for Breast Cancer in Elderly Women.

    Published in:
    2022
    By:
    • Guillerm, S Ophie;
    • Bourstyn, Edwige;
    • Itti, Ramona;
    • Cahen-Doidy, Laurence;
    • Quéro, Laurent;
    • Labidi, Mouna;
    • Marchand, Eva;
    • Lorphelin, Henri;
    • Giacchetti, Sylvie;
    • Cuvier, Caroline;
    • Espié, Marc;
    • Teixeira, Luis;
    • Hennequin, Christophe
    Publication type:
    journal article
    4
    5
    6
    7
    8
    9
    10

    Estrogen receptor-positive/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography/computed tomography during neoadjuvant chemotherapy.

    Published in:
    2013
    By:
    • Groheux, David;
    • Hatt, Mathieu;
    • Hindié, Elif;
    • Giacchetti, Sylvie;
    • de Cremoux, Patricia;
    • Lehmann-Che, Jacqueline;
    • Martineau, Antoine;
    • Marty, Michel;
    • Cuvier, Caroline;
    • Cheze-Le Rest, Catherine;
    • de Roquancourt, Anne;
    • Visvikis, Dimitris;
    • Espié, Marc
    Publication type:
    journal article
    11
    12
    13
    14
    15

    TP53 Status and Response to Chemotherapy in Breast Cancer.

    Published in:
    Pathobiology, 2008, v. 75, n. 2, p. 132, doi. 10.1159/000123851
    By:
    • Bertheau, Philippe;
    • Espié, Marc;
    • Turpin, Elisabeth;
    • Lehmann, Jacqueline;
    • Plassa, Louis-François;
    • Varna, Mariana;
    • Janin, Anne;
    • de Thé, Hugues
    Publication type:
    Article
    16

    Distinct tumor protein p53 mutants in breast cancer subgroups.

    Published in:
    International Journal of Cancer, 2013, v. 132, n. 5, p. 1227, doi. 10.1002/ijc.27767
    By:
    • Dumay, Anne;
    • Feugeas, Jean‐Paul;
    • Wittmer, Evelyne;
    • Lehmann‐Che, Jacqueline;
    • Bertheau, Philippe;
    • Espié, Marc;
    • Plassa, Louis‐François;
    • Cottu, Paul;
    • Marty, Michel;
    • André, Fabrice;
    • Sotiriou, Christos;
    • Pusztai, Lajos;
    • de Thé, Hugues
    Publication type:
    Article
    17

    Prospective Multicenter Study Validate a Prediction Model for Surgery Uptake Among Women with Atypical Breast Lesions.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 4, p. 2138, doi. 10.1245/s10434-020-09107-z
    By:
    • Uzan, Catherine;
    • Mazouni, Chafika;
    • Rossoni, Caroline;
    • De Korvin, Brigitte;
    • de Lara, Christine Tunon;
    • Cohen, Monique;
    • Chabbert, Nathalie;
    • Zilberman, Sonia;
    • Boussion, Veronique;
    • Vincent Salomon, Anne;
    • Espie, Marc;
    • Coutant, Charles;
    • Marchal, Frederic;
    • Salviat, Flore;
    • Boulanger, Loic;
    • Doutriaux-Dumoulin, Isabelle;
    • Jouve, Eva;
    • Mathelin, Carole;
    • de Saint hilaire, Pierre;
    • Mollard, Joelle
    Publication type:
    Article
    18
    19
    20
    21
    22

    Triple-Negative Breast Cancer: Early Assessment with <sup>18</sup>F-FDG PET/CT During Neoadjuvant Chemotherapy Identifies Patients Who Are Unlikely to Achieve a Pathologic Complete Response and Are at a High Risk of Early Relapse.

    Published in:
    Journal of Nuclear Medicine, 2012, v. 53, n. 2, p. 249, doi. 10.2967/jnumed.111.094045
    By:
    • Groheux, David;
    • Hindié, Elif;
    • Giacchetti, Sylvie;
    • Delord, Marc;
    • Hamy, Anne-Sophie;
    • de Roquancourt, Anne;
    • Vercellino, Laetitia;
    • Berenger, Nathalie;
    • Marty, Michel;
    • Espié, Marc
    Publication type:
    Article
    23
    24
    25
    26
    27

    Do clinical, histological or immunohistochemical primary tumour characteristics translate into different F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2015, v. 42, n. 11, p. 1682, doi. 10.1007/s00259-015-3110-x
    By:
    • Groheux, David;
    • Majdoub, Mohamed;
    • Tixier, Florent;
    • Rest, Catherine;
    • Martineau, Antoine;
    • Merlet, Pascal;
    • Espié, Marc;
    • Roquancourt, Anne;
    • Hindié, Elif;
    • Hatt, Mathieu;
    • Visvikis, Dimitris
    Publication type:
    Article
    28
    29
    30

    Should FDG PET/CT be used for the initial staging of breast cancer?

    Published in:
    European Journal of Nuclear Medicine & Molecular Imaging, 2009, v. 36, n. 10, p. 1539, doi. 10.1007/s00259-009-1159-0
    By:
    • Groheux, David;
    • Hindié, Elif;
    • Rubello, Domenico;
    • Espié, Marc;
    • Baillet, Georges;
    • Giacchetti, Sylvie;
    • Misset, Jean-Louis;
    • Moretti, Jean-Luc
    Publication type:
    Article
    31

    Breast Intracystic Papillary Carcinoma: An Update.

    Published in:
    Breast Journal, 2009, v. 15, n. 6, p. 639, doi. 10.1111/j.1524-4741.2009.00823.x
    By:
    • Calderaro, Julien;
    • Espie, Marc;
    • Duclos, Juliette;
    • Giachetti, Sylvie;
    • Wehrer, Delphine;
    • Sandid, Wissam;
    • Cahen-Doidy, Laurence;
    • Albiter, Marcella;
    • Janin, Anne;
    • de Roquancourt, Anne
    Publication type:
    Article
    32
    33

    Negative Relationship between Post-Treatment Stromal Tumor-Infiltrating Lymphocyte (TIL) and Survival in Triple-Negative Breast Cancer Patients Treated with Dose-Dense Dose-Intense NeoAdjuvant Chemotherapy.

    Published in:
    Cancers, 2022, v. 14, n. 5, p. 1331, doi. 10.3390/cancers14051331
    By:
    • Giacchetti, Sylvie;
    • Faucheux, Lilith;
    • Gardair, Charlotte;
    • Cuvier, Caroline;
    • de Roquancourt, Anne;
    • Campedel, Luca;
    • Groheux, David;
    • de Bazelaire, Cedric;
    • Lehmann-Che, Jacqueline;
    • Miquel, Catherine;
    • Cahen Doidy, Laurence;
    • Amellou, Malika;
    • Madelaine, Isabelle;
    • Reyal, Fabien;
    • Someil, Laetitia;
    • Hocini, Hamid;
    • Hennequin, Christophe;
    • Teixeira, Luis;
    • Espié, Marc;
    • Chevret, Sylvie
    Publication type:
    Article
    34

    Prognostic Impact of Stromal Immune Infiltration before and after Neoadjuvant Chemotherapy (NAC) in Triple Negative Inflammatory Breast Cancers (TNIBC) Treated with Dose-Dense Dose-Intense NAC.

    Published in:
    Cancers, 2020, v. 12, n. 9, p. 2657, doi. 10.3390/cancers12092657
    By:
    • Campedel, Luca;
    • Blanc-Durand, Paul;
    • Bin Asker, Asker;
    • Lehmann-Che, Jacqueline;
    • Cuvier, Caroline;
    • De Bazelaire, Cedric;
    • Teixeira, Luis;
    • Becourt, Stephanie;
    • Ledoux, Florence;
    • Hocini, Hamid;
    • Bourstyn, Edwige;
    • Miquel, Catherine;
    • Guillerm, Sophie;
    • Charveriat, Patrick;
    • Espié, Marc;
    • De Roquancourt, Anne;
    • Hamy, Anne-Sophie;
    • Giacchetti, Sylvie
    Publication type:
    Article
    35
    36
    37

    Prospective analysis of the impact of VEGF-A gene polymorphisms on the pharmacodynamics of bevacizumab-based therapy in metastatic breast cancer patients.

    Published in:
    British Journal of Clinical Pharmacology, 2011, v. 71, n. 6, p. 921, doi. 10.1111/j.1365-2125.2010.03896.x
    By:
    • Etienne-Grimaldi, Marie-Christine;
    • Formento, Patricia;
    • Degeorges, Armelle;
    • Pierga, Jean-Yves;
    • Delva, Rémi;
    • Pivot, Xavier;
    • Dalenc, Florence;
    • Espié, Marc;
    • Veyret, Corinne;
    • Formento, Jean-Louis;
    • Francoual, Mireille;
    • Piutti, Magali;
    • de Crémoux, Patricia;
    • Milano, Gérard
    Publication type:
    Article
    38

    A multicenter randomized phase II study of sequential epirubicin/cyclophosphamide followed by docetaxel with or without celecoxib or trastuzumab according to HER2 status, as primary chemotherapy for localized invasive breast cancer patients.

    Published in:
    Breast Cancer Research & Treatment, 2010, v. 122, n. 2, p. 429, doi. 10.1007/s10549-010-0939-3
    By:
    • Pierga, Jean-Yves;
    • Delaloge, Suzette;
    • Espié, Marc;
    • Brain, Etienne;
    • Sigal-Zafrani, Brigitte;
    • Mathieu, Marie-Christine;
    • Bertheau, Philippe;
    • Guinebretière, Jean;
    • Spielmann, Marc;
    • Savignoni, Alexia;
    • Marty, Michel
    Publication type:
    Article
    39
    40
    41

    Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.

    Published in:
    Breast Cancer Research, 2013, v. 15, n. 3, p. 1, doi. 10.1186/bcr3421
    By:
    • Lehmann-Che, Jacqueline;
    • Hamy, Anne-Sophie;
    • Porcher, Raphaël;
    • Barritault, Marc;
    • Bouhidel, Fatiha;
    • Habuellelah, Hanadi;
    • Leman-Detours, Solenne;
    • Roquancourt, Anne de;
    • Cahen-Doidy, Laurence;
    • Bourstyn, Edwige;
    • Cremoux, Patricia de;
    • Bazelaire, Cedric de;
    • Albiter, Marcela;
    • Giacchetti, Sylvie;
    • Cuvier, Caroline;
    • Janin, Anne;
    • Espié, Marc;
    • Thé, Hugues de;
    • Bertheau, Philippe
    Publication type:
    Article
    42
    43
    44

    Concomitant medication, comorbidity and survival in patients with breast cancer.

    Published in:
    Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-47002-3
    By:
    • Dumas, Elise;
    • Rejo, Beatriz Grandal;
    • Gougis, Paul;
    • Houzard, Sophie;
    • Abécassis, Judith;
    • Jochum, Floriane;
    • Marande, Benjamin;
    • Ballesta`, Annabelle;
    • Nery, Elaine Del;
    • Dubois, Thierry;
    • Alsafadi, Samar;
    • Asselain, Bernard;
    • Latouche, Aurélien;
    • Espie, Marc;
    • Laas, Enora;
    • Coussy, Florence;
    • Bouchez, Clémentine;
    • Pierga, Jean-Yves;
    • Bihan-Benjamin, Christine Le;
    • Bousquet, Philippe-Jean
    Publication type:
    Article
    45

    Actionability of HER2-amplified circulating tumor cells in HER2-negative metastatic breast cancer: the CirCe T-DM1 trial.

    Published in:
    2019
    By:
    • Jacot, William;
    • Cottu, Paul;
    • Berger, Frederique;
    • Dubot, Coraline;
    • Venat-Bouvet, Laurence;
    • Lortholary, Alain;
    • Bourgeois, Hugues;
    • Bollet, Marc;
    • Servent, Veronique;
    • Luporsi, Elisabeth;
    • Espié, Marc;
    • Guiu, Severine;
    • D'Hondt, Veronique;
    • Dieras, Veronique;
    • Sablin, Marie-Paule;
    • Brain, Etienne;
    • Neffati, Souhir;
    • Pierga, Jean-Yves;
    • Bidard, Francois-Clement
    Publication type:
    journal article
    46
    47

    Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer.

    Published in:
    Breast Cancer Research & Treatment, 2021, v. 189, n. 2, p. 377, doi. 10.1007/s10549-021-06143-5
    By:
    • Dent, Rebecca;
    • Oliveira, Mafalda;
    • Isakoff, Steven J.;
    • Im, Seock-Ah;
    • Espié, Marc;
    • Blau, Sibel;
    • Tan, Antoinette R.;
    • Saura, Cristina;
    • Wongchenko, Matthew J.;
    • Xu, Na;
    • Bradley, Denise;
    • Reilly, Sarah-Jayne;
    • Mani, Aruna;
    • Kim, Sung-Bae;
    • on behalf of the LOTUS investigators;
    • Lee, K. S.;
    • Sohn, J. H.;
    • Kim, J. H.;
    • Seo, J. H.;
    • Kim, J. S.
    Publication type:
    Article
    48
    49

    The Chinese Monoid.

    Published in:
    International Journal of Algebra & Computation, 2001, v. 11, n. 3, p. 301, doi. 10.1142/S0218196701000425
    By:
    • Cassaigne, Julien;
    • Espie, Marc;
    • Krob, Daniel;
    • Novelli, Jean-Christophe;
    • Hivert, Florent;
    • Pin, J.-E.
    Publication type:
    Article